tiprankstipranks

Mark Plavsic Insider Profile

4 Followers
Mark Plavsic, CTO at Fate Therapeutics, holds 121.13K shares in Aura Biosciences Inc (Ticker: AURA), holds 123.70K shares in Fate Therapeutics (Ticker: FATE). Most recently, Mark Plavsic Sold ― shares of Aura Biosciences Inc on Oct 16, 2024 for an estimated value of 72.72K.
tipranks
Mark Plavsic

Mark Plavsic
Fate Therapeutics (FATE)
CTO

Ranked #21,200 out of 99,335 Corporate Insiders

Profitable Transactions

67%
2 out of 3 Profitable Transactions

Average Return

+33.20%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$1M
80.03%
19.97%
A breakdown of Mark Plavsic's holdings

Insider Roles

Aura Biosciences Inc
(AURA)
Chief Technology Officer
Fate Therapeutics
(FATE)
CTO
Roles that Mark Plavsic holds in companies

Most Profitable Insider Trade

Stock:
Fate Therapeutics
(FATE)
Rating:Informative Sell
Date:Jul 06, 2022 - Jul 06, 2023
Return:+83.60%
The most profitable trade made by Mark Plavsic

Mark Plavsic's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Fate Therapeutics
Jan 11, 2023
CTO
Informative Sell
17.91K
$269.68K
Aura Biosciences Inc
Oct 16, 2024
Chief Technology Officer
Informative Sell
72.72K
$1.08M
List of latest transactions for each holding click on a transaction to see Mark Plavsic's performance on stock

Mark Plavsic insider profile FAQ

What is the percentage of profitable transactions made by Mark Plavsic?
The percentage of profitable transactions made by Mark Plavsic is 67%.
    What is the average return per transaction made by Mark Plavsic?
    The average return per transaction made by Mark Plavsic is 33.20%.
      What stocks does Mark Plavsic hold?
      Mark Plavsic holds: FATE, AURA stocks.
        What was Mark Plavsic’s latest transaction?
        Mark Plavsic latest transaction was an Informative Sell of $72.72K.
          What was Mark Plavsic's most profitable transaction?
          Mark Plavsic’s most profitable transaction was an Informative Sell of FATE stock on July 6, 2022. The return on the trade was 83.60%.
            What is Mark Plavsic's role in Fate Therapeutics?
            Mark Plavsic's role in Fate Therapeutics is CTO.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.